PATENT CLAIM ANALYSIS

Application Number: 16039947
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["540", "500000"]

Abstract:
Compounds represented by the following general formula (I), which has a P2X4 receptor antagonistic activity (in the formula, R 1 , R 2  and R 3  represent hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a halogen atom, and the like, X represents C or N, Y represents N or C(═O), provided that when X is C, Y represents N, and when X is N, Y represents C(═O), the double line consisting of the solid line and the broken line represents a single bond or double bond, n represents an integer of 0 to 6, Z represents O, S, or an atomic bond, and A represents benzene ring, pyridine ring, and the like).

Claim (Index 3):
The compound according to  claim 1 , a tautomer or a stereoisomer of the compound, or a pharmacologically acceptable salt thereof, wherein R 2  represent hydrogen atom.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 95.0
- Lexical Diversity: 2.22857
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14903343', '15923685', '15176857', '14371868', '14903382']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7320951217300664
- 35 USC 102 Novelty (BERT): 0.5982323092133642
- Combined Prediction Score: 0.7187088404783962
- Mean Citation Score: 449.1418019999999
- Max Citation Score: 515.3993
- Similarity Product: 434.6316138951064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test